The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Iterum Therapeutics plc(NASDAQ:ITRM) 
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials ...
Website: http://www.iterumtx.com
Founded: 2015
Full Time Employees: 44
Sector: Healthcare
Industry: Biotechnology
Iterum Therapeutics plc Days Payable Outstanding ttm (DPO)
Iterum Therapeutics plc Op Cashflow Per Share ttm
Iterum Therapeutics plc Free Cashflow Per Share ttm
Iterum Therapeutics plc Cash Per Share ttm
Iterum Therapeutics plc (GAAP) P/E ratio ttm
Iterum Therapeutics plc P/B ratio ttm
No extra charts and metrics for this ticker.